PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-09-21

Date Title Company
21-Sep-2023 Envirotainer expands network capabilities in Americas to meet growing market demand Envirotainer
21-Sep-2023 Seraxis Announces Closing of Second VC Tranche and Successful Completion of Preclinical Studies of Pancreatic Organoids From Seraxis’ Novel Pancreas-Derived Stem Cells Newswire
21-Sep-2023 Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director And Enters Cooperation Agreement with Shareholder MKT Capital Businesswire
21-Sep-2023 ICON plc Schedules Third Quarter 2023 Earnings Conference Call Businesswire
21-Sep-2023 CHEPLAPHARM succesfully places additional notes in a volume of €300m Cheplapharm AG
21-Sep-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
21-Sep-2023 Quebec-based hospitals pilot nasal photodisinfection to reduce antibiotic resistance Ondine Biomedical
21-Sep-2023 Launch of innovative Cardio-diabetes clinic in Lincolnshire improves outcomes for patients with diabetes following a heart attack Boehringer Ingelheim
21-Sep-2023 Leucid Bio Granted MHRA Clinical Trial Authorisation for Lateral NKG2D CAR-T Cell Therapy LEU011 Leucid Bio
21-Sep-2023 EARLY GENETIC ANALYSIS OF ADVANCED AND METASTATIC BILIARY TRACT CANCER TO OPTIMIZE SECOND-LINE THERAPY Karl Landsteiner University of Health Sciences
21-Sep-2023 Interim results for the six months ended 30 June 2023 BenevolentAI
21-Sep-2023 2023 State of Tech in Biopharma Report Reveals Tech Strategies in Era of Data + AI Benchling
21-Sep-2023 Santa Barbara Surgery Center is First in Southern California to Adopt New Wireless Technology for Arthroscopy De La Vina Surgicenter
21-Sep-2023 Transgene advances its innovative immunotherapy pipeline and extends financial visibility until the end of 2024 Transgene
21-Sep-2023 Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-treat Cancers Businesswire
21-Sep-2023 argenx Announces VYVGART (efgartigimod alfa) Authorized for Sale by Health Canada for Generalized Myasthenia Gravis argenx
21-Sep-2023 Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets Abbott
21-Sep-2023 Novo Nordisk and UNICEF to extend joint initiative to prevent global childhood obesity Novo Nordisk
21-Sep-2023 BeiGene Announces Positive Regulatory Updates in Europe and the U.S. After Recently Regaining Global Rights for TEVIMBRA® BeiGene
21-Sep-2023 BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody TEVIMBRA® (tislelizumab) BeiGene